Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Phenserine efficacy in Alzheimer's disease.
J Alzheimers Dis. 2010;22(4):1201-8. doi: 10.3233/JAD-2010-101311.
J Alzheimers Dis. 2010.
PMID: 20930279
Free PMC article.
Clinical Trial.
Patients who completed 12 weeks of the double-blind before others were continued in the double-blind to determine longer-term treatment effects. At 12 weeks, mean ADAS-cog (AD assessment scale-cognitive) changes from baseline were -2.5 and -1.9 for high-dose phenserine (n= …
Patients who completed 12 weeks of the double-blind before others were continued in the double-blind to determine longer-term treatme …
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study.
Rogers SL, Friedhoff LT.
Rogers SL, et al. Among authors: friedhoff lt.
Eur Neuropsychopharmacol. 1998 Feb;8(1):67-75. doi: 10.1016/s0924-977x(97)00079-5.
Eur Neuropsychopharmacol. 1998.
PMID: 9452942
Clinical Trial.
The long-term efficacy and safety of donepezil (up to 10 mg/day) was evaluated in a multicentre, non-randomised, open-label extension study of 133 patients with mild to moderate Alzheimer's disease (AD) who had completed a previous 14-week double-blind, placebo-controlled …
The long-term efficacy and safety of donepezil (up to 10 mg/day) was evaluated in a multicentre, non-randomised, open-label extension …
Item in Clipboard
Cite
Cite